Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

A new study suggests that mRNA vaccines for COVID-19 could help boost the effects of immunotherapy drugs for some cancer patients.

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

To further back their findings, University of Florida researchers replicated the effect in mice. They paired immunotherapy ...

The observation also marks a significant step toward a long-awaited universal cancer vaccine to boost the tumor-fighting ...

As the U.S. pulls the funding rug out from under African countries fighting infectious diseases, it is more necessary than ...

"What the recent CDC recommendations suggest is that people with more domain-specific knowledge about immunization are needed ...

Then came the fallout: Levi was spreading conspiracy theories and murdering children, said one member in a WhatsApp group ...

With the three healthcare stocks featured below, any "buying the dip" in them today could prove to be a regretful mistake in hindsight.

To tailor cancer therapies to individual patients, Moderna, BioNTech and other companies are rethinking how they optimize ...